CMS
Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ
The settlement includes the resolution of allegations brought in two separate actions filed against the firm under the whistleblower provisions of the False Claims Act.
US Wins $370M Judgment in Lab Fraud Case
A US district court awarded the judgment against a Kentucky lab owner accused of billing Medicare for molecular testing not ordered by a healthcare provider.
FDA's recommendation that Alzheimer's patients be tested for APOE status prior to starting the drug could lead to new regulatory approvals and payor coverage.
The high-coverage whole-genome assay is covered for patients with myeloid neoplasms, including acute myeloid leukemia and myelodysplastic syndrome.
Kentucky Lab Owner, Exec Plead Guilty to $2.8M Lab Fraud Scheme
Ronald Coburn and Erica Baker of Louisville-based LabTox submitted urine drug tests ordered by courts and from nonmedical sober homes to Medicare and Medicaid.